ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

DeVita Considers Laetrile Tests

June 3, 1977

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

November 15, 2013

Grassley Seeks Data On Sponsored Travel By NCI Scientists

October 29, 2010

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009

NIH Introduces “Modular” Gran Application And Awards

February 26, 1999

Board approves continuation of partnerships between minority institutions and cancer centers for research, training, and outreach.

July 9, 2004